These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The business case for workplace alcohol prevention. Knott B. Occup Health Saf; 2012 Oct; 81(10):107-8, 110. PubMed ID: 23094492 [No Abstract] [Full Text] [Related]
5. Overview on drug and alcohol testing in the workplace. Hanson M. Bull Narc; 1993 Oct; 45(2):3-44. PubMed ID: 7920541 [Abstract] [Full Text] [Related]
6. Errors in assessing DSM-IV substance use disorders. Grant BF, Compton WM, Crowley TJ, Hasin DS, Helzer JE, Li TK, Rounsaville BJ, Volkow ND, Woody GE. Arch Gen Psychiatry; 2007 Mar; 64(3):379-80; author reply 381-2. PubMed ID: 17339528 [No Abstract] [Full Text] [Related]
7. Health promotion in the workplace: alcohol and drug abuse. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser; 1993 Mar; 833():1-34. PubMed ID: 8367980 [No Abstract] [Full Text] [Related]
8. Substance abuse in the workplace: epidemiology, effects, and industry response. Bush DM, Autry JH. Occup Med; 2002 Mar; 17(1):13-25, iii. PubMed ID: 11726333 [Abstract] [Full Text] [Related]
9. Drugs and alcohol in the workplace. Jones R. Occup Health (Lond); 1996 Nov; 48(11):396-9. PubMed ID: 9283471 [No Abstract] [Full Text] [Related]
10. Substance abusers. Terminate or treat? Gemignani J. Bus Health; 1999 Jun; 17(6):32-4, 37-9. PubMed ID: 10538201 [No Abstract] [Full Text] [Related]
11. The user in the next cubicle. Finley M. Minn Med; 2007 Sep; 90(9):16-7. PubMed ID: 17966256 [No Abstract] [Full Text] [Related]
12. Drug screening & the ADA. Watts C. Occup Health Saf; 2001 Apr; 70(4):80-2. PubMed ID: 11326588 [No Abstract] [Full Text] [Related]
13. Drug-free workplace programmes: New Zealand perspective. Nolan S. Forensic Sci Int; 2008 Jan 30; 174(2-3):125-32. PubMed ID: 17467938 [Abstract] [Full Text] [Related]